Editas Medicine, Inc.
USD3.21
+0.01 (+0.16%)
CEO
Gilmore O'Neill
IPO Date
2016-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.21
Prev. Close
$3.20
Day Low
$3.11
Day High
$3.27
52W Low
$1.66
52W High
$4.54
Market Cap
$0.31B
Volume
0.81M
| -0.4 |
| 31 Dec 2023 | FY | 92.2% | -196.1% | -43.9% | -30.7% | 0.14 | 5.39 | -5.0 |
| 31 Dec 2022 | FY | 67.9% | -1118.3% | -61.1% | -42.9% | 0.12 | 5.94 | -2.8 |
| 31 Dec 2021 | FY | 80.2% | -753.6% | -34.8% | -28.4% | 0.05 | 10.82 | -9.3 |
| 31 Dec 2020 | FY | -74.1% | -127.8% | -29.5% | -20.3% | 0.07 | 7.20 | -35.4 |
| 31 Dec 2019 | FY | -372.0% | -651.4% | -51.0% | -26.3% | 0.11 | 7.74 | -11.1 |
| 31 Dec 2018 | FY | -183.9% | -344.3% | -46.6% | -26.2% | 0.14 | 10.44 | -9.7 |
| 31 Dec 2017 | FY | -505.8% | -876.5% | -57.8% | -32.2% | 0.16 | 9.05 | -10.3 |
| 31 Dec 2016 | FY | -841.3% | -1605.5% | -72.2% | -42.4% | 0.26 | 5.66 | -5.4 |
| -8.1 |
| 30 Sept 2025 | Q3 | 100.0% | -333.0% | -186.7% | -12.4% | 1.46 | 2.86 | -3.1 |
| 30 Jun 2025 | Q2 | 100.0% | -1487.8% | -277.4% | -25.3% | 1.10 | 2.77 | -0.9 |
| 31 Mar 2025 | Q1 | 100.0% | -1633.5% | -121.9% | -28.9% | 0.50 | 3.08 | -0.3 |
| 31 Dec 2024 | Q4 | 100.0% | -148.3% | -33.8% | -13.3% | 0.26 | 3.75 | -0.6 |
| 30 Sept 2024 | Q3 | -2521.3% | -101870.5% | -35.4% | -19.0% | 0.22 | 3.75 | -1.1 |
| 30 Jun 2024 | Q2 | -176.8% | -13178.8% | -29.1% | -17.6% | 0.17 | 3.85 | -1.4 |
| 31 Mar 2024 | Q1 | -24.1% | -5458.1% | -21.0% | -14.1% | 0.12 | 4.60 | -2.4 |
| 31 Dec 2023 | Q4 | 97.6% | -31.4% | -5.4% | -3.8% | 0.14 | 5.39 | -11.0 |